We are live on ! Find out more
TROVW

TrovaGene, Inc. Warrant

Delisted

TROVW was delisted on the 30th of May, 2017.

4 hedge funds and large institutions have $3.98M invested in TrovaGene, Inc. Warrant in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more call options, than puts

Call options by funds: $242K | Put options by funds: $33K

100% more funds holding

Funds holding: 24 (+2)

80% more capital invested

Capital invested by funds: $2.21M → $3.98M (+$1.77M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
2
Closed
Calls
$242K
Puts
$33K
Net Calls
+$209K
Net Calls Change
+$198K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$37.3K
2
Citadel Advisors
Citadel Advisors
Florida
+$1.28K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$3.94M -$320 -50 -0%
Morgan Stanley
2
Morgan Stanley
New York
$44K +$37.3K +5,840 New
Citadel Advisors
3
Citadel Advisors
Florida
$1K +$1.28K +200 New
TRCT
4
Tower Research Capital (TRC)
New York
-$594 -93 -62%

TROVW Hedge Fund Activity: Q2 2015 in Review

4 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q2 2015, worth a combined $3.98M — up 80% from $2.21M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TROVW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $37.3K. The largest seller was Tower Research Capital (TRC), cutting an estimated $594.

  • 4 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q2 2015, up from 2 in Q1 2015.
  • Funds reported $3.98M of TrovaGene, Inc. Warrant stock for Q2 2015, up 80% quarter-over-quarter.
  • 2 funds opened new TrovaGene, Inc. Warrant positions in Q2 2015 and 0 closed out, a net change of +2 holders.
  • The largest TrovaGene, Inc. Warrant buyer in Q2 2015 was Morgan Stanley, an estimated $37.3K added.
  • The largest TrovaGene, Inc. Warrant seller in Q2 2015 was Tower Research Capital (TRC), an estimated $594 sold.

Based on aggregated 13F filings for Q2 2015.